Zogenix Asset Utilization:
0.544 for Dec. 31, 2012Zogenix Historical Asset Utilization Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 0.544 |
| Sept. 30, 2012 | 0.4452 |
| June 30, 2012 | 0.4916 |
| March 31, 2012 | 0.7015 |
| Dec. 31, 2011 | 0.44 |
| Sept. 30, 2011 | 0.3645 |
| June 30, 2011 | 0.6603 |
| March 31, 2011 | 0.5256 |
About Asset Utilization
The asset utilization ratio calculates the total revenue earned for every dollar of assets a company owns.
For example, with an asset utilization ratio of 52%, a company earned $.52 for each dollar of assets held by the company. An increasing asset utilization means the company is being more efficient with each dollar of assets it has.
This ratio is frequently used to compare a company's efficiency over time.
Learn More
ZGNX Asset Utilization Benchmarks
| Companies | |
|---|---|
| GlaxoSmithKline | 0.632 |
| Tetraphase Pharmaceuticals | |
| Zoetis | 0.7127 |
ZGNX Asset Utilization Rankings
| Overall |
65th percentile 2627 of 7593 |
| Sector |
55th percentile 290 of 650 in Healthcare |
| Industry |
69th percentile 16 of 52 in Drug Manufacturers - Major |
ZGNX Asset Utilization Range, Past 5 Years
| Minimum | 0.3645 | Sep 2011 |
| Maximum | 0.7015 | Mar 2012 |
| Average | 0.5216 |
ZGNX News
Impax Labs (IPXL), Zogenix (ZGNX) Rise as FDA Won't Block Generic Opana (ENDP)
Street Insider May 10
Street Insider May 10